Wendy Moore to Anti-Asthmatic Agents
This is a "connection" page, showing publications Wendy Moore has written about Anti-Asthmatic Agents.
Connection Strength
2.948
-
Moore WC, Panettieri RA, Trevor J, Ledford DK, Lugogo N, Soong W, Chipps BE, Carr W, Belton L, Gandhi H, Trudo F, Ambrose CS. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Ann Allergy Asthma Immunol. 2020 09; 125(3):294-303.e1.
Score: 0.698
-
Moore WC, Castro M. The Many "Buckets" of Severe Asthma: Moving Toward Personalized Management. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):936-937.
Score: 0.575
-
Opina MT, Moore WC. Phenotype-Driven Therapeutics in Severe Asthma. Curr Allergy Asthma Rep. 2017 Feb; 17(2):10.
Score: 0.559
-
Moore WC. Update in asthma 2007. Am J Respir Crit Care Med. 2008 May 15; 177(10):1068-73.
Score: 0.305
-
Moore WC, Peters SP. Severe asthma: an overview. J Allergy Clin Immunol. 2006 Mar; 117(3):487-94; quiz 495.
Score: 0.262
-
Fitzpatrick AM, Moore WC. Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment? J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):901-908.
Score: 0.144
-
Peters SP, Bleecker ER, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger LC, Engle LL, Dimango EA, Israel E, Kraft M, Lazarus SC, Lemanske RF, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Szefler SJ. Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol. 2013 Nov; 132(5):1068-1074.e1.
Score: 0.111
-
Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010 Feb 15; 181(4):315-23.
Score: 0.085
-
Moore WC. Update in asthma 2008. Am J Respir Crit Care Med. 2009 May 15; 179(10):869-74.
Score: 0.082
-
Moore WC, Peters SP. Update in asthma 2006. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):649-54.
Score: 0.071
-
Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, Kazani SD, Moore WC, Moy J, Sorkness CA, Avila P, Bacharier LB, Bleecker E, Boushey HA, Chmiel J, Fitzpatrick AM, Gentile D, Hundal M, Israel E, Kraft M, Krishnan JA, LaForce C, Lazarus SC, Lemanske R, Lugogo N, Martin RJ, Mauger DT, Naureckas E, Peters SP, Phipatanakul W, Que LG, Sheshadri A, Smith L, Solway J, Sullivan-Vedder L, Sumino K, Wechsler ME, Wenzel S, White SR, Sutherland ER. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May; 311(20):2083-91.
Score: 0.029
-
Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ER. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ß agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med. 2014 Mar; 2(3):204-13.
Score: 0.028